Gaspersz, Roxanne
Lamers, Femke
Wittenberg, Gayle
Beekman, Aartjan T. F.
van Hemert, Albert M.
Schoevers, Robert A.
Penninx, Brenda W. J. H.
Article History
Received: 23 May 2017
Revised: 25 July 2017
Accepted: 17 August 2017
First Online: 8 December 2017
Competing interests
: B.W.J.H.P. has received (non-related) research funding from Janssen Research & Development, LLC, and Boehringer Ingelheim. F.L. has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PCIG12-GA-2012-334065. G.W. is a full-time employee of Janssen Research & Development, LLC, and holds stock in Johnson & Johnson. A.T.F.B. has served as a speaker for Lundbeck. The remaining authors declare that they have no competing financial interests.